Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Azilsartan Medoxomil Potassium Tablets

Approval Number

国药准字H20253694

Company江苏联环药业股份有限公司

Registration Date

March 25, 2025

Drug Information

Generic Name

美阿沙坦钾片

Dosage Form

片剂

Strength

按美阿沙坦（C₃₀H₂₄N₄O₈）计80 mg

Drug Type

化学药品

Registration Date

March 25, 2025

Company Information

Applicant Company

Company Name江苏联环药业股份有限公司

Company Address

江苏省扬州市扬州生物健康产业园健康一路9号

Manufacturing Company

Company Name江苏联环药业股份有限公司

Company Address

江苏省扬州市扬州生物健康产业园健康一路9号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy